Kelly Deck - Jan 3, 2023 Form 4 Insider Report for Inhibrx, Inc. (INBX)

Role
Chief Financial Officer
Signature
/s/ Kelly D. Deck, attorney-in-fact
Stock symbol
INBX
Transactions as of
Jan 3, 2023
Transactions value $
$0
Form type
4
Date filed
1/3/2023, 05:09 PM
Previous filing
Jan 25, 2022
Next filing
Mar 6, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBX Stock Option (right to buy) Award $0 +30K $0.00 30K Jan 3, 2023 Common Stock 30K $23.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on January 3, 2024, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.